This inventor holds 1 USPTO granted patent. Top assignee: University of Pittsburgh. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Carole Frye: Innovator in Transgenic Research
Introduction
Carole Frye is a distinguished inventor based in Pittsburgh, PA (US). She has made significant contributions to the field of biomedical research, particularly in the development of transgenic models for studying cardiac dysfunction.
Latest Patents
Carole Frye holds a patent for "Transgenic mice containing a nucleic acid encoding tumor necrosis." This invention provides transgenic nonhuman mammals that exhibit elevated levels of tumor necrosis factor alpha in myocardium relative to nontransgenic control mammals. The patent also outlines methods for creating these transgenic non-human mammals and identifies agents useful in the treatment and prevention of cardiac dysfunction.
Career Highlights
Carole Frye is affiliated with the University of Pittsburgh, where she conducts her research. Her work has been pivotal in advancing our understanding of cardiac health and disease.
Collaborations
She has collaborated with notable colleagues, including Charles F McTiernan and Arthur M Feldman, enhancing the impact of her research through teamwork and shared expertise.
Conclusion
Carole Frye's innovative work in transgenic research exemplifies her commitment to advancing medical science and improving health outcomes. Her contributions continue to influence the field significantly.